SynthesisBMC cancer2025

The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review.

Lingbo Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.